Background: The net effect of unilateral carotid endarterectomy (CEA), on baroreflex sensitivity, depends on the counteraction of various suggested mechanisms. Aim: To investigate if the morphology of carotid plaque is another factor that can affect baroreflex function. Methods: Forty-two patients (27 male; mean age 69.09 years) were evaluated. Patients were classified into 2 groups, preoperatively, according to the echogenicity of the plaque, (Gray-Waele classification). Plaques of grades 1 and 2 were defined as echolucent plaques and those of grades 3 and 4 were defined as echogenic. All patients were subjected to elective CEA, using ultraluminal carotid shunt and vein patch. Spontaneous baroreflex sensitivity (sBRS), as a reliable index of responsiveness of the baroreflex, was calculated with the sequence method. Preoperative patient characteristics were compared using the x2 test, Fisher’s exact test, or the independent samples t test. We evaluated hemodynamic parameters, without taking into account the echogenicity of the plaque, using Friedman and Wilcoxon tests. Hemodynamic parameters between the 2 groups of plaques were calculated with multiple and simple analysis of covariance. Results: Patients with echolucent plaques had diabetes mellitus and symptomatic plaques at a significantly greater incidence ( 2=8.077, p=0.004, #ι 2=8.576, p=0.003 respectively). There was an overall reducing of sBRS after CEA, ( 2=32.605, p<0,001). Before endarterectomy, sBRS was greater in patients with echolucent plaques, compared to patients with echogenic plaques (F=10.065, p=0.003). Postoperatively this difference was eliminated. Conclusions: Only preoperatively echogenicity can affect baroreflex function in patients with carotid artery disease. This finding has a special clinical impact in these patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.